BRAF V600E変異は,MAPK経路遺伝子の発現に変化する腫瘍特異的な影響を及ぼし,患者の結果に影響を与える可能性があります
Sourat Darabi1, Phillip Stafford1,2,3, David R Braxton1
1Hoag Family Cancer Institute, Newport Beach, CA 92663, USA.
International journal of molecular sciences
|August 28, 2025
まとめ
BRAF阻害剤はメラノーマには有効ですが,甲状腺癌には有効ではありません. この研究では,BRAF変異を有するメラノーマではミトゲン活性化タンパク質キナーゼ (MAPK) 経路の活性化が増加したが,甲状腺がんではそうではなかった.
科学分野:
- 腫瘍学
- 分子生物学
- 遺伝学
背景:
- BRAF阻害剤は,メラノーマと甲状腺がんの治療において,異なる有効性を示しています.
- 異なる反応は,下流のミトゲン活性化タンパク質キナーゼ (MAPK) 経路の遺伝子活性化または発現に起因する可能性があります.
- これらの分子の違いを理解することは 癌治療の最適化に不可欠です
研究 の 目的:
- BRAF変異のメラノーマと甲状腺がんにおけるMAPK経路の微分活性化を調査する.
- MAPK経路の活性化とBRAF阻害剤への反応を相関させる.
- BRAF阻害剤の効果の差異に寄与する分子因子を特定する.
主な方法:
- メラノーマと甲状腺がん患者の全エクソームとトランスクリプトームの配列解析
- 10のMAPK関連遺伝子のZスコア正常化表現に基づくMAPK活性化スコア (MPAS) の計算.
- 腫瘍登録から得られた臨床結果データと遺伝学的結果の相関関係
主要な成果:
- BRAF V600E変異は17%のメラノーマと39%の甲状腺がんで発見されました.
- BRAF V600E変異を持つメラノーマは,BRAFとMAPK経路の遺伝子発現が増加した (p=0. 02).
- 甲状腺がんにおけるBRAF V600E変異は,MAPK経路の活性化の増加と関連していなかった.
結論:
- MAPK経路は,BRAF変異にもかかわらず,メラノーマと甲状腺がんでは異動的に活性化されます.
- メラノーマにおけるMAPK経路活性化の増加は,BRAF阻害剤に対するより高い応答率に寄与する可能性があります.
- これらの発見は,標的がん治療のための経路特異分子プロファイルの重要性を強調しています.
さらに関連する動画
08:18Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma
Published on: September 8, 2021
3.0K
07:49Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
6.2K
関連する概念動画
MAPK Signaling Cascades
6.0K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.0K
The Ras Gene
6.4K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.4K
Interactions Between Signaling Pathways
6.4K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K
The Retinoblastoma Gene
4.2K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K
NF-κB-dependent Signaling Pathway
7.8K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.8K
Mismatch Repair
5.2K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
5.2K
